MSFT vs WFC: Which Is the Better Buy?

Side-by-side comparison of Microsoft Corporation and Wells Fargo & Company β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-19.
Microsoft Corporation Β· Technology
$497.12
+41.3% upside to fair value
High Conviction Grade A High Quality
VS
Wells Fargo & Company Β· Financial Services
$86.12
+20.4% upside to fair value
Med Conviction Grade B
QuantHub Verdict
MSFT has more upside to fair value (+41.3%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MSFT WFC
Current Price $497.12 $86.12
Fair Value Estimate $702.35 $103.68
Upside to Fair Value +41.3% +20.4%
Market Cap $3,691.4B $260.4B
Forward P/E β€” β€”
EV / EBITDA 18.3x 15.6x
Price / Sales 11.1x 2.0x
Price / FCF 55.1x 13.7x
Revenue Growth YoY +17.7% +11.3%
Gross Margin 67.9% 64.5%
Operating Margin 46.8% 21.2%
Return on Equity 33.2% 12.6%
Dividend Yield 0.73% 2.15%
FCF Yield 1.81% 7.3%
Analyst Consensus Strong Buy Hold
Investment Thesis
MSFT β€” Microsoft Corporation
Microsoft is a global infrastructure-software platform spanning Azure, Microsoft 365, security, Dynamics, Windows, GitHub and AI copilots, with high business quality supported by enterprise distribution, explicitly cited switching costs, a $678 billion commercial RPO balance, 67.9% TTM gross margin, 46.8% TTM operating margin, 40.3% TTM net margin and 33.2% ROE. Revenue grew 17.7% and earnings gr…
WFC β€” Wells Fargo & Company
Wells Fargo is a diversified U.S. bank with roughly 197,000 employees operating four segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth and Investment Management. The business quality is solid but not exceptional: trailing return on equity is 12.6%, TTM net margin is 17.5%, and revenue grew 11.3% year over year in the most recent quarter while…
Accumulation Zones
Metric MSFT WFC
Zone Low $526.76 $77.76
Zone High $597.00 $88.13
In Buy Zone? Yes Yes
← MSFT Research    WFC Research β†’    All Research